Viewing StudyNCT06414135



Ignite Creation Date: 2024-05-19 @ 5:35 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06414135
Status: RECRUITING
Last Update Posted: 2024-06-26
First Post: 2024-05-06

Brief Title: Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis
Sponsor: Liangjing Lu
Organization: RenJi Hospital

Conditions & Keywords Data

Conditions:
Name
Systemic Sclerosis
Keywords:
Name View
B cell depletion View
CAR-T cell therapy View
systemic sclerosis View